Therefore, it can be inferred that TNFAIP3 is a key effector of ZSH‐2208, which inhibits the growth of ESCC‐TRCs by indirectly reducing its expression through the inhibition of RARγ protein expression. This evidence concerns the gene RARG and esophageal squamous cell carcinoma.